A Novel Therapeutic Target for Mitochondrial Dysfunction
Mitochondrial dysfunction contributes significantly to a wide range of chronic diseases. This dysregulation in mitochondrial function can lead to cellular damage, ultimately resulting in various pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising strategy for addressing this debilitating condition. EPT Fumarate operate